Market Tracker

02/17 5:16pm ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

5.09
Delayed Data
As of Feb 17
 +0.04 / +0.79%
Today’s Change
3.05
Today|||52-Week Range
9.72
-3.78%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close5.05
Today’s open5.04
Day’s range5.00 - 5.10
Volume15,035
Average volume (3 months)153,662
Market cap$21.6M
Dividend yield--
Data as of 3:29pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+49.44%
Earnings growth (this year)+27.96%
Earnings growth (next 5 years)--
Revenue growth (last year)+12.11%
P/E ratioNM
Price/Sales8.37
Price/Book0.80

Competitors

 Today’s
change
Today’s
% change
CBLICleveland Biolabs In...+0.14+7.53%
TNXPTonix Pharmaceutical...+0.00+0.74%
NEOTNeothetics Inc+0.13+8.84%
INNLInnocoll Holdings PL...+0.00+0.03%
Data as of 3:59pm ET, 02/17/2017

Financials

Next reporting dateMarch 29, 2017
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$1.9M
Annual profit (last year)-$14.3M
Net profit margin-737.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts